Coherently with the role of EXO1 in promoting cGAS positive MN in a SETX deficient background, we found that in ovarian cancer, head and neck squamous cell carcinoma and glioma the concurrent presence of low SETX and high EXO1 expression levels leads to poor survival. This evidence concerns the gene SETX and glioma.